POST Online Media Lite Edition



 

Cephalon: J. Kevin Buchi CEO and member of the board

Staff writer |
Frazer, Pa., USA - December 23, 2010, Frazer, Pa., USA - Cephalon, Inc., a global biopharmaceutical company, announced that it has appointed J. Kevin Buchi as chief executive officer and a member of the company's board.



Mr. Buchi was appointed Chief Operating Officer of Cephalon in 2010. From 1996 to 2009, Mr. Buchi served as Chief Financial Officer and, from 2004, head of business development for the company. At various times in his career at Cephalon, he has had oversight of corporate finance, accounting, information systems, facilities, human resources and administration. Mr. Buchi joined Cephalon in 1991 as controller.

Mr. Buchi graduated from Cornell University with a Bachelor of Arts degree in chemistry. He was a synthetic organic chemist for the Eastman Kodak Company before going on to obtain a master's degree in management from the J.L. Kellogg Graduate School of Management at Northwestern University.

LATEST 5 MOVES FROM Pennsylvania 


What to read next

Impax adds J. Kevin Buchi to board of directors
Cephalon announces executive leadership changes
Impax Laboratories announces leadership transition